Metagenomi Therapeutics (MGX) Other Accumulated Expenses (2024 - 2026)
Metagenomi Therapeutics (MGX) reported Other Accumulated Expenses of $228000.0 for Q1 2026, up 94.87% year-over-year from $117000.0 in Q1 2025, and up 38.18% quarter-over-quarter from $165000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Other Accumulated Expenses (2024 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 3 years of Other Accumulated Expenses data on file, last reported at $228000.0 in Q1 2026.
- Other Accumulated Expenses for Q1 2026 came in at $228000.0, up 94.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $228000.0 (up 94.87% YoY), and the FY2025 annual result was $165000.0, down 63.0% from the prior year.
- Other Accumulated Expenses grew to $228000.0 in Q1 2026 per MGX's latest filing, from $165000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $446000.0 in Q4 2024 and troughed at $117000.0 in Q1 2025.
- A 3-year average of $257333.3 and a median of $252000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Accumulated Expenses slumped 63.0% in 2025, then jumped 94.87% in 2026.
- A 3-year view of Other Accumulated Expenses shows it stood at $446000.0 in 2024, then plunged by 63.0% to $165000.0 in 2025, then jumped by 38.18% to $228000.0 in 2026.
- Business Quant data shows MGX's Other Accumulated Expenses at $228000.0 in Q1 2026, $165000.0 in Q4 2025, and $312000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 165,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 276,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Dec 31, 2024 | 446,000.00 |